Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure

被引：44
|
作者：
Prebet, Thomas [1 ,2 ,3 ]
Gore, Steven D. [1 ,3 ]
Thepot, Sylvain [3 ]
Esterni, Benjamin [2 ]
Quesnel, Bruno [3 ]
Rauzy, Odile Beyne [3 ]
Dreyfus, Francois [3 ]
Gardin, Claude [3 ]
Fenaux, Pierre [3 ]
Vey, Norbert [2 ,3 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Dept Hematol Malignancies, Baltimore, MD 21218 USA
[2] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France
[3] Grp Francophone Myelodysplasies, Bobigny, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷 / 06期
关键词：
Myelodysplasia; acute myeloid leukaemia; azacitidine; relapse; outcome; CONVENTIONAL CARE REGIMENS;
D O I：
10.1111/j.1365-2141.2012.09076.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：764 / 766
页数：3
相关论文
共 50 条
  • [1] Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
    Edlin, R.
    Connock, M.
    Tubeuf, S.
    Round, J.
    Fry-Smith, A.
    Hyde, C.
    Greenheld, W.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 69 - 74
  • [2] Acute myeloid leukaemia following myelodysplastic syndrome
    Divane, A.
    Paterakis, G.
    Chantzi, F.
    Kitra, V.
    Karamolegou, K.
    Sandu-Tsoutsou, A.
    Georgakopoulos, N.
    Moschovi, M.
    CHROMOSOME RESEARCH, 2009, 17 : 145 - 145
  • [3] Poor Outcome of Patients With Myelodysplastic Syndrome After Azacitidine Treatment Failure
    Duong, Vu H.
    Lin, Karen
    Reljic, Tea
    Kumar, Ambuj
    Al Ali, Najla H.
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rami S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (06): : 711 - 715
  • [4] Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia
    Scott, Lesley J.
    DRUGS, 2016, 76 (08) : 889 - 900
  • [5] Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia
    Lesley J. Scott
    Drugs, 2016, 76 : 889 - 900
  • [6] Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure
    Prebet, Thomas
    Gore, Steven D.
    Esterni, Benjamin
    Gardin, Claude
    Itzykson, Raphael
    Thepot, Sylvain
    Dreyfus, Francois
    Rauzy, Odile Beyne
    Recher, Christian
    Ades, Lionel
    Quesnel, Bruno
    Beach, C. L.
    Fenaux, Pierre
    Vey, Norbert
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3322 - 3327
  • [7] Poor Outcome of Patients with Myelodysplastic Syndrome (MDS) After Azacitidine Treatment Failure
    Lin, Karen
    Reljic, Tea
    Kumar, Ambuj
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2010, 116 (21) : 1199 - 1200
  • [8] Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
    Prebet, Thomas
    Charbonnier, Aude
    Gelsi-Boyer, Veronique
    Mozziconacci, Marie Joelle
    Blaise, Didier
    Vey, Norbert
    LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1538 - 1540
  • [9] NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia
    Miller, Whitney
    Holden, Joanne
    George, Elisabeth
    Stein, Ken
    LANCET ONCOLOGY, 2011, 12 (04): : 326 - 327
  • [10] AZACITIDINE FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    Gritsaev, S., V
    Martynkevich, I. S.
    Kostroma, I. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (01): : 23 - 29
12345